Bioventus Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bioventus Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q3 2024.
  • Bioventus Inc. Nonoperating Income (Expense) for the quarter ending September 28, 2024 was -$8.91M, a 16.1% increase year-over-year.
  • Bioventus Inc. Nonoperating Income (Expense) for the twelve months ending September 28, 2024 was -$39M, a 16.4% increase year-over-year.
  • Bioventus Inc. annual Nonoperating Income (Expense) for 2023 was -$39.4M, a 80.7% decline from 2022.
  • Bioventus Inc. annual Nonoperating Income (Expense) for 2022 was -$21.8M, a 747% decline from 2021.
  • Bioventus Inc. annual Nonoperating Income (Expense) for 2021 was -$2.57M, a 51.7% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$39M -$8.91M +$1.7M +16.1% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-05
Q2 2024 -$40.7M -$10.1M +$1.02M +9.16% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-06
Q1 2024 -$41.7M -$10.4M -$2.3M -28.3% Jan 1, 2024 Mar 30, 2024 10-Q 2024-05-07
Q4 2023 -$39.4M -$9.57M +$7.23M +43% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$46.6M -$10.6M -$6.89M -185% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$39.7M -$11.1M -$7.92M -249% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-06
Q1 2023 -$31.8M -$8.11M -$10M -524% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-07
Q4 2022 -$21.8M -$16.8M -$17.2M -4301% Oct 2, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$4.59M -$3.72M -$1.62M -76.8% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-07
Q2 2022 -$2.97M -$3.18M +$144K +4.33% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 -$3.12M $1.91M -$544K -22.1% Jan 1, 2022 Apr 2, 2022 10-Q 2023-05-16
Q4 2021 -$2.57M $400K Oct 3, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 -$2.1M -$3.51M -250% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-21
Q2 2021 -$3.33M -$1.83M -122% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-12
Q1 2021 $2.46M Jan 1, 2021 Apr 3, 2021 10-Q 2022-05-11
Q3 2020 $1.41M Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-10
Q2 2020 -$1.5M Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.